Dr. Reddys Laboratories Ltd.

Dr. Reddy's Laboratories has informed that the Company has filed its unaudited condensed consolidated interim financial statements prepared under IFRS in Form 6-K for the quarter ended December 31, 2021, with the United States Securities and Exchange Commission on January 28, 2022. A copy of the Form 6-K is attached. The Form 6-K is also available on the Company's website, www.drreddys.com.

The above information is a part of company’s filings submitted to BSE.